EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Natural cycle versus hormone replacement therapy for endometrial preparation before frozen embryo transfer in ovulatory women: a meta-analysis of randomised controlled trials.

Dr. Neha, Dr Mini Bedi, Dr Prashant Patil

SJ Gynecology and Obstetrics Africa · 01.08.2026 · 3 (3) · 17

DOI: 10.51168/0phkqp21 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift SJ Gynecology and Obstetrics Africa, online erschienen am 01.08.2026. Verfasst von Dr. Neha und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hormone replacement therapy (HRT) for frozen embryo transfer removes the corpus luteum, whose absence cohort studies link to pregnancy complications. Methodology: Randomised trials comparing natural or modified natural cycle (NC) preparation with HRT in ovulatory women were identified from an author-assembled collection and a targeted registry check, without a systematic database search. Risk ratios (RR) were pooled per randomised woman using REML random effects with modified Hartung–Knapp intervals, and certainty was graded with GRADE; secondary analyses were post hoc.

Results

Eleven RCTs (9995 women) were included; nine contributed to the primary analyses. In six trials, all giving luteal support in NC cycles, miscarriage per randomised woman was lower with NC (RR 0.79, 95% CI 0.64–0.97; about 20 fewer per 1000 women, 3 to 34), though PnROVE carried 73% of the weight. Clinical pregnancy did not differ (RR 1.07, 0.97–1.17). Live birth was marginally higher (9 trials, 9226 women; RR 1.11, 1.00–1.23), but the lower limit fell below 1 when any of six trials was omitted, and the largest trial found no difference. Cancellation did not differ on average across protocol trials (risk difference +0.6 points, −5.4 to +6.6), but PnROVE found 4.7 more cancellations per 100 with NC. Pre-eclampsia (RR 0.69, 0.48–0.99) and hypertensive disorders (0.76, 0.60–0.97) per woman favoured NC under fixed effects only.

Conclusion

In ovulatory women, NC preparation with luteal support may reduce miscarriage by about 20 per 1000 women without lowering pregnancy rates. A live-birth benefit is unproven. Recommendation: Ovulatory women can be offered NC with counselling on its higher cancellation risk. Future trials should be powered for pre-eclampsia, recruit in South Asia and standardise luteal support in NC cycles.

Zitieren

APA

Neha, D., Bedi, D. M., & Patil, D. P. (2026). Natural cycle versus hormone replacement therapy for endometrial preparation before frozen embryo transfer in ovulatory women: a meta-analysis of randomised controlled trials. SJ Gynecology and Obstetrics Africa, 3(3), 17. https://doi.org/10.51168/0phkqp21

Vancouver

Neha D, Bedi DM, Patil DP. Natural cycle versus hormone replacement therapy for endometrial preparation before frozen embryo transfer in ovulatory women: a meta-analysis of randomised controlled trials. SJ Gynecology and Obstetrics Africa. 2026;3(3):17. doi:10.51168/0phkqp21

BibTeX
@article{Neha2026,
  author = {Neha, Dr. and Bedi, Dr Mini and Patil, Dr Prashant},
  title = {Natural cycle versus hormone replacement therapy for endometrial preparation before frozen embryo transfer in ovulatory women: a meta-analysis of randomised controlled trials},
  journal = {SJ Gynecology and Obstetrics Africa},
  year = {2026},
  volume = {3},
  number = {3},
  pages = {17},
  doi = {10.51168/0phkqp21}
}
Kostenlos starten →